Indian pharma sector emerges as favourite destination for foreign investors, says Health Minister Mansukh Mandaviya

The Union Minister for Health and Family Welfare, Mansukh Mandaviya, on Wednesday, said that the pharmaceutical industry of India has emerged as a favorite destination for foreign investors. The coronavirus pandemic has accelerated the growth of the country's pharmaceutical industry.

"Indian pharmaceutical sector under PM @NarendraModi Ji's leadership has emerged as a favourite destination for foreign investors," Dr. Mansukh Mandaviya tweeted.

He further said that India’s pharma sector witnessed unprecedented growth of 202% despite the covid-19 pandemic. It took two years to register that kind of surge. The FDI inflows in 2019-2020 were Rs 3,650 which increased to Rs 11,015 crore in the year 2021-2022.

Indian pharmaceutical sector under PM @NarendraModi Ji's leadership has emerged as a favourite destination for foreign investors.

Despite #Covid19, FDI inflows in India's pharmaceutical sector witnessed unprecedented growth of 202% #IndiaPharma #IndiaMedicalDevice pic.twitter.com/OTGDIsKTKq

— Dr Mansukh Mandaviya (@mansukhmandviya) April 27, 2022

“Despite #Covid19, FDI inflows in India’s pharmaceutical sector witnessed unprecedented growth of 202%,” he tweeted.

The cases of coronavirus are again increasing in India. Prime Minister Narendra Modi held a meeting with the Chief Ministers of all the states today on the matter of Coronavirus. The major reason for this meeting is also clear from the cases of coronavirus that came today.

In India, 2927 cases of coronavirus have been reported in the last 24 hours. Out of these, 1203 cases i.e. almost half are from Delhi. However, it is a matter of relief that the total number of deaths in India is not very high. This time there are only a few serious cases of coronavirus.